Drug-Induced Mitochondrial Dysfunction

┬╖
┬╖ John Wiley & Sons
рей.реж
реи рдкрд░реАрдХреНрд╖рдг
рдИ-рдкреБрд╕реНрддрдХ
652
рдкреЗрдЬ
рд░реЗрдЯрд┐рдВрдЧ рдЖрдгрд┐ рдкрд░реАрдХреНрд╖рдгреЗ рдпрд╛рдВрдЪреА рдкрдбрддрд╛рд│рдгреА рдХреЗрд▓реЗрд▓реА рдирд╛рд╣реА ┬ардЕрдзрд┐рдХ рдЬрд╛рдгреВрди рдШреНрдпрд╛

рдпрд╛ рдИ-рдкреБрд╕реНрддрдХрд╛рд╡рд┐рд╖рдпреА

This is the definitive, one-stop resource on preclinical drug evaluation for potential mitochondrial toxicity, addressing the issue upfront in the drug development process. It discusses mitochondrial impairment to organs, skeletal muscle, and nervous systems and details methodologies used to assess mitochondria function. It covers both in vitro and in vivo methods for analysis and includes the latest models. This is the authoritative reference on drug-induced mitochondrial dysfunction for safety assessment professionals in the pharmaceutical industry and for pharmacologists and toxicologists in both drug and environmental health sciences.

рд░реЗрдЯрд┐рдВрдЧ рдЖрдгрд┐ рдкреБрдирд░рд╛рд╡рд▓реЛрдХрдиреЗ

рей.реж
реи рдкрд░реАрдХреНрд╖рдгреЗ

рд▓реЗрдЦрдХрд╛рд╡рд┐рд╖рдпреА

James A. Dykens, PhD, is an Associate Research Fellow in Pfizer's Drug Safety Research and Development Department. Currently in Sandwich, England, he previously worked in a similar role with Pfizer in La Jolla, California. Prior to his work with Pfizer, Dr. Dykens was the senior director of technology development for MIGENIX Inc., a senior scientist and the director of business development at MitoKor, Inc., and a senior principal scientist at Parke-Davis Pharmaceutical Research. Dr. Dykens has published extensively on drug-induced mitochondrial dysfunction, on the role of mitochondrial free radical production in the etiology of neurodegenerative diseases, and on the physiological ecology of marine symbioses.

Yvonne Will, PhD, works in Pfizer's Exploratory Safety Differentiation Group in Groton, Connecticut. Prior to this position, she led Pfizer's Investigative Biochemical Toxicity Group within the Drug Safety Research and Development Department in La Jolla. Before joining Pfizer, Dr. Will worked on mitochondrial proteomics and physiology at MitoKor, Inc. Dr. Will has authored a host of articles and book chapters. She is a member of the Society of Toxicology and a frequent speaker for groups like ACT and World Pharmaceutical Congress.

рдпрд╛ рдИ-рдкреБрд╕реНрддрдХрд▓рд╛ рд░реЗрдЯрд┐рдВрдЧ рджреНрдпрд╛

рддреБрдореНрд╣рд╛рд▓рд╛ рдХрд╛рдп рд╡рд╛рдЯрддреЗ рддреЗ рдЖрдореНрд╣рд╛рд▓рд╛ рд╕рд╛рдВрдЧрд╛.

рд╡рд╛рдЪрди рдорд╛рд╣рд┐рддреА

рд╕реНрдорд╛рд░реНрдЯрдлреЛрди рдЖрдгрд┐ рдЯреЕрдмрд▓реЗрдЯ
Android рдЖрдгрд┐ iPad/iPhone рд╕рд╛рдареА Google Play рдмреБрдХ рдЕтАНреЕрдк рдЗрдВрд╕реНтАНрдЯреЙрд▓ рдХрд░рд╛. рд╣реЗ рддреБрдордЪреНтАНрдпрд╛ рдЦрд╛рддреНтАНрдпрд╛рдиреЗ рдЖрдкреЛрдЖрдк рд╕рд┐рдВрдХ рд╣реЛрддреЗ рдЖрдгрд┐ рддреБрдореНтАНрд╣реА рдЬреЗрдереЗ рдХреБрдареЗ рдЕрд╕рд╛рд▓ рддреЗрдереВрди рддреБрдореНтАНрд╣рд╛рд▓рд╛ рдСрдирд▓рд╛рдЗрди рдХрд┐рдВрд╡рд╛ рдСрдлрд▓рд╛рдЗрди рд╡рд╛рдЪрдгреНтАНрдпрд╛рдЪреА рдЕрдиреБрдорддреА рджреЗрддреЗ.
рд▓реЕрдкрдЯреЙрдк рдЖрдгрд┐ рдХреЙрдВрдкреНрдпреБрдЯрд░
рддреБрдореНрд╣реА рддреБрдордЪреНрдпрд╛ рдХрд╛рдБрдкреНрдпреБрдЯрд░рдЪрд╛ рд╡реЗрдм рдмреНрд░рд╛рдЙрдЭрд░ рд╡рд╛рдкрд░реВрди Google Play рд╡рд░ рдЦрд░реЗрджреА рдХреЗрд▓реЗрд▓реА рдСрдбрд┐рдУрдмреБрдХ рдРрдХреВ рд╢рдХрддрд╛.
рдИрд╡рд╛рдЪрдХ рдЖрдгрд┐ рдЗрддрд░ рдбрд┐рд╡реНрд╣рд╛рдЗрд╕реЗрд╕
Kobo eReaders рд╕рд╛рд░рдЦреНрдпрд╛ рдИ-рдЗрдВрдХ рдбрд┐рд╡реНтАНрд╣рд╛рдЗрд╕рд╡рд░ рд╡рд╛рдЪрдгреНтАНрдпрд╛рд╕рд╛рдареА, рддреБрдореНрд╣реА рдПрдЦрд╛рджреА рдлрд╛рдЗрд▓ рдбрд╛рдЙрдирд▓реЛрдб рдХрд░реВрди рддреА рддреБрдордЪреНтАНрдпрд╛ рдбрд┐рд╡реНтАНрд╣рд╛рдЗрд╕рд╡рд░ рдЯреНрд░рд╛рдиреНрд╕рдлрд░ рдХрд░рдгреЗ рдЖрд╡рд╢реНрдпрдХ рдЖрд╣реЗ. рд╕рдкреЛрд░реНрдЯ рдЕрд╕рд▓реЗрд▓реНрдпрд╛ eReaders рд╡рд░ рдлрд╛рдЗрд▓ рдЯреНрд░рд╛рдиреНрд╕рдлрд░ рдХрд░рдгреНрдпрд╛рд╕рд╛рдареА, рдорджрдд рдХреЗрдВрджреНрд░ рдордзреАрд▓ рддрдкрд╢реАрд▓рд╡рд╛рд░ рд╕реВрдЪрдирд╛ рдлреЙрд▓реЛ рдХрд░рд╛.